Global Separation Systems for Commercial Biotechnology

Separation Systems for Commercial Biotechnology Comprehensive Study by Application (Vaccines, Hormones, Proteins, Enzymes, Others), End-User (Pharmaceutical, Food & Cosmetics, Agriculture, Life Sciences Research, Others), Method (Liquid Chromatography, Membrane Filtration, Electrophoresis, Niche Separation, Centrifugation, Lab-on-a-Chip, Others) Players and Region - Global Market Outlook to 2026

Separation Systems for Commercial Biotechnology Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 4.5%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Separation Systems for Commercial Biotechnology Market Scope
Bioseparation systems are used for the purification and separation of biological products and the equipment used for the separation of biological material from complex mixture or solution includes chromatography, membrane filters, and centrifuges. HPLC is one of the most commonly used separative techniques and also one of the fastest-growing instrumentation fields in the world. HPLCS are considered standard analytical tools in the laboratory to accurately isolate and purify organic molecules, drugs, and some peptide hormones. The United States is a recognized leader in analytical instrumentation used in biological research and thus stands at the forefront of many of the technical innovations being made in the bioprocess field.

The Separation Systems for Commercial Biotechnology market study is segmented, by Application (Vaccines, Hormones, Proteins, Enzymes and Others) and major geographies with country level break-up. According to AMA, the Global Separation Systems for Commercial Biotechnology market is expected to see growth rate of 4.5%

Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Separation Systems for Commercial Biotechnology market throughout the predicted period.

Thermo Fisher Scientific (United States), Danaher Corporation (United States), Agilent Technologies (United States), Waters Corporation (United States), Shimadzu Corporation (Japan), Bio-Rad Laboratories (United States), Merck & Co., Inc. (United States), QIAGEN (Germany), Sartorius (Germany) and PerkinElmer, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Hitachi Koki Co. (Japan), Miltenyi Biotec (Germany), Varian (United States), Affymetrix (United States) and Alfa Wassermann (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Separation Systems for Commercial Biotechnology market by Type, Application and Region.

On the basis of geography, the market of Separation Systems for Commercial Biotechnology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies

On January 2, 2020, Thermo Fisher Scientific and Agilent Technologies has announced that they are continuing their agreement to the industry-wide Instrument Control Exchange Program (ICEP) to foster compatibility among key vendors' instrumentation and chromatography data systems (CDS).
Products produced from protein separation systems processes must be produced in accordance with FDA good manufacturing practices (GMP) guidelines. Thus, these separation procedures and equipment must pass FDA audits of the manufacturing process.

Market Trend
  • Ultrafiltration and Other Filtration Systems
  • HPLCS to Monitor Bioprocesses and Purify Large Quantities of Proteins such as Leukocyte Interferon

Market Drivers
  • The growing number of biotech firms with huge investments in research and development is the key driving factor for the growth of the market.
  • Stringent Government Rules & Regulations
  • Technological Advancement in the Biotechnology Sector

Opportunities
  • The use of rDNA technology to produce low-volume, high value-added products as well as high-volume products has greatly increased the need to develop more economic bioprocesses.

Restraints
  • Lack of Improvisation in Electrophoresis Equipment Technology
  • High Cost of Technologies & Systems

Challenges
  • Intense Competition in R&D to Develop Improved Large-Scale Separation and Purification Methods


Key Target Audience
Separation System Manufacturers, Pharmaceutical and Biotechnology Firms, Biomedical Researchers, Research Institutes and Laboratories and Industry Bodies & Associations

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Application
  • Vaccines
  • Hormones
  • Proteins
  • Enzymes
  • Others
By End-User
  • Pharmaceutical
  • Food & Cosmetics
  • Agriculture
  • Life Sciences Research
  • Others

By Method
  • Liquid Chromatography
  • Membrane Filtration
  • Electrophoresis
  • Niche Separation
  • Centrifugation
  • Lab-on-a-Chip
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The growing number of biotech firms with huge investments in research and development is the key driving factor for the growth of the market.
      • 3.2.2. Stringent Government Rules & Regulations
      • 3.2.3. Technological Advancement in the Biotechnology Sector
    • 3.3. Market Challenges
      • 3.3.1. Intense Competition in R&D to Develop Improved Large-Scale Separation and Purification Methods
    • 3.4. Market Trends
      • 3.4.1. Ultrafiltration and Other Filtration Systems
      • 3.4.2. HPLCS to Monitor Bioprocesses and Purify Large Quantities of Proteins such as Leukocyte Interferon
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Separation Systems for Commercial Biotechnology, by Application, End-User, Method and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Separation Systems for Commercial Biotechnology (Value)
      • 5.2.1. Global Separation Systems for Commercial Biotechnology by: Application (Value)
        • 5.2.1.1. Vaccines
        • 5.2.1.2. Hormones
        • 5.2.1.3. Proteins
        • 5.2.1.4. Enzymes
        • 5.2.1.5. Others
      • 5.2.2. Global Separation Systems for Commercial Biotechnology by: End-User (Value)
        • 5.2.2.1. Pharmaceutical
        • 5.2.2.2. Food & Cosmetics
        • 5.2.2.3. Agriculture
        • 5.2.2.4. Life Sciences Research
        • 5.2.2.5. Others
      • 5.2.3. Global Separation Systems for Commercial Biotechnology by: Method (Value)
        • 5.2.3.1. Liquid Chromatography
        • 5.2.3.2. Membrane Filtration
        • 5.2.3.3. Electrophoresis
        • 5.2.3.4. Niche Separation
        • 5.2.3.5. Centrifugation
        • 5.2.3.6. Lab-on-a-Chip
        • 5.2.3.7. Others
      • 5.2.4. Global Separation Systems for Commercial Biotechnology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Separation Systems for Commercial Biotechnology (Volume)
      • 5.3.1. Global Separation Systems for Commercial Biotechnology by: Application (Volume)
        • 5.3.1.1. Vaccines
        • 5.3.1.2. Hormones
        • 5.3.1.3. Proteins
        • 5.3.1.4. Enzymes
        • 5.3.1.5. Others
      • 5.3.2. Global Separation Systems for Commercial Biotechnology by: End-User (Volume)
        • 5.3.2.1. Pharmaceutical
        • 5.3.2.2. Food & Cosmetics
        • 5.3.2.3. Agriculture
        • 5.3.2.4. Life Sciences Research
        • 5.3.2.5. Others
      • 5.3.3. Global Separation Systems for Commercial Biotechnology by: Method (Volume)
        • 5.3.3.1. Liquid Chromatography
        • 5.3.3.2. Membrane Filtration
        • 5.3.3.3. Electrophoresis
        • 5.3.3.4. Niche Separation
        • 5.3.3.5. Centrifugation
        • 5.3.3.6. Lab-on-a-Chip
        • 5.3.3.7. Others
      • 5.3.4. Global Separation Systems for Commercial Biotechnology Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Separation Systems for Commercial Biotechnology (Price)
  • 6. Separation Systems for Commercial Biotechnology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Danaher Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Agilent Technologies (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Waters Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Shimadzu Corporation (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bio-Rad Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Merck & Co., Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. QIAGEN (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sartorius (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PerkinElmer, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Separation Systems for Commercial Biotechnology Sale, by Application, End-User, Method and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Separation Systems for Commercial Biotechnology (Value)
      • 7.2.1. Global Separation Systems for Commercial Biotechnology by: Application (Value)
        • 7.2.1.1. Vaccines
        • 7.2.1.2. Hormones
        • 7.2.1.3. Proteins
        • 7.2.1.4. Enzymes
        • 7.2.1.5. Others
      • 7.2.2. Global Separation Systems for Commercial Biotechnology by: End-User (Value)
        • 7.2.2.1. Pharmaceutical
        • 7.2.2.2. Food & Cosmetics
        • 7.2.2.3. Agriculture
        • 7.2.2.4. Life Sciences Research
        • 7.2.2.5. Others
      • 7.2.3. Global Separation Systems for Commercial Biotechnology by: Method (Value)
        • 7.2.3.1. Liquid Chromatography
        • 7.2.3.2. Membrane Filtration
        • 7.2.3.3. Electrophoresis
        • 7.2.3.4. Niche Separation
        • 7.2.3.5. Centrifugation
        • 7.2.3.6. Lab-on-a-Chip
        • 7.2.3.7. Others
      • 7.2.4. Global Separation Systems for Commercial Biotechnology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Separation Systems for Commercial Biotechnology (Volume)
      • 7.3.1. Global Separation Systems for Commercial Biotechnology by: Application (Volume)
        • 7.3.1.1. Vaccines
        • 7.3.1.2. Hormones
        • 7.3.1.3. Proteins
        • 7.3.1.4. Enzymes
        • 7.3.1.5. Others
      • 7.3.2. Global Separation Systems for Commercial Biotechnology by: End-User (Volume)
        • 7.3.2.1. Pharmaceutical
        • 7.3.2.2. Food & Cosmetics
        • 7.3.2.3. Agriculture
        • 7.3.2.4. Life Sciences Research
        • 7.3.2.5. Others
      • 7.3.3. Global Separation Systems for Commercial Biotechnology by: Method (Volume)
        • 7.3.3.1. Liquid Chromatography
        • 7.3.3.2. Membrane Filtration
        • 7.3.3.3. Electrophoresis
        • 7.3.3.4. Niche Separation
        • 7.3.3.5. Centrifugation
        • 7.3.3.6. Lab-on-a-Chip
        • 7.3.3.7. Others
      • 7.3.4. Global Separation Systems for Commercial Biotechnology Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Separation Systems for Commercial Biotechnology (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Separation Systems for Commercial Biotechnology: by Application(USD Million)
  • Table 2. Separation Systems for Commercial Biotechnology Vaccines , by Region USD Million (2015-2020)
  • Table 3. Separation Systems for Commercial Biotechnology Hormones , by Region USD Million (2015-2020)
  • Table 4. Separation Systems for Commercial Biotechnology Proteins , by Region USD Million (2015-2020)
  • Table 5. Separation Systems for Commercial Biotechnology Enzymes , by Region USD Million (2015-2020)
  • Table 6. Separation Systems for Commercial Biotechnology Others , by Region USD Million (2015-2020)
  • Table 7. Separation Systems for Commercial Biotechnology: by End-User(USD Million)
  • Table 8. Separation Systems for Commercial Biotechnology Pharmaceutical , by Region USD Million (2015-2020)
  • Table 9. Separation Systems for Commercial Biotechnology Food & Cosmetics , by Region USD Million (2015-2020)
  • Table 10. Separation Systems for Commercial Biotechnology Agriculture , by Region USD Million (2015-2020)
  • Table 11. Separation Systems for Commercial Biotechnology Life Sciences Research , by Region USD Million (2015-2020)
  • Table 12. Separation Systems for Commercial Biotechnology Others , by Region USD Million (2015-2020)
  • Table 13. Separation Systems for Commercial Biotechnology: by Method(USD Million)
  • Table 14. Separation Systems for Commercial Biotechnology Liquid Chromatography , by Region USD Million (2015-2020)
  • Table 15. Separation Systems for Commercial Biotechnology Membrane Filtration , by Region USD Million (2015-2020)
  • Table 16. Separation Systems for Commercial Biotechnology Electrophoresis , by Region USD Million (2015-2020)
  • Table 17. Separation Systems for Commercial Biotechnology Niche Separation , by Region USD Million (2015-2020)
  • Table 18. Separation Systems for Commercial Biotechnology Centrifugation , by Region USD Million (2015-2020)
  • Table 19. Separation Systems for Commercial Biotechnology Lab-on-a-Chip , by Region USD Million (2015-2020)
  • Table 20. Separation Systems for Commercial Biotechnology Others , by Region USD Million (2015-2020)
  • Table 21. South America Separation Systems for Commercial Biotechnology, by Country USD Million (2015-2020)
  • Table 22. South America Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 23. South America Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 24. South America Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 25. Brazil Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 26. Brazil Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 27. Brazil Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 28. Argentina Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 29. Argentina Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 30. Argentina Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 31. Rest of South America Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 32. Rest of South America Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 33. Rest of South America Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 34. Asia Pacific Separation Systems for Commercial Biotechnology, by Country USD Million (2015-2020)
  • Table 35. Asia Pacific Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 36. Asia Pacific Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 37. Asia Pacific Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 38. China Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 39. China Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 40. China Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 41. Japan Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 42. Japan Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 43. Japan Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 44. India Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 45. India Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 46. India Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 47. South Korea Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 48. South Korea Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 49. South Korea Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 50. Taiwan Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 51. Taiwan Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 52. Taiwan Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 53. Australia Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 54. Australia Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 55. Australia Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 56. Rest of Asia-Pacific Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 57. Rest of Asia-Pacific Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 58. Rest of Asia-Pacific Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 59. Europe Separation Systems for Commercial Biotechnology, by Country USD Million (2015-2020)
  • Table 60. Europe Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 61. Europe Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 62. Europe Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 63. Germany Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 64. Germany Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 65. Germany Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 66. France Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 67. France Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 68. France Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 69. Italy Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 70. Italy Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 71. Italy Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 72. United Kingdom Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 73. United Kingdom Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 74. United Kingdom Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 75. Netherlands Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 76. Netherlands Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 77. Netherlands Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 78. Rest of Europe Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 79. Rest of Europe Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 80. Rest of Europe Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 81. MEA Separation Systems for Commercial Biotechnology, by Country USD Million (2015-2020)
  • Table 82. MEA Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 83. MEA Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 84. MEA Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 85. Middle East Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 86. Middle East Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 87. Middle East Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 88. Africa Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 89. Africa Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 90. Africa Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 91. North America Separation Systems for Commercial Biotechnology, by Country USD Million (2015-2020)
  • Table 92. North America Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 93. North America Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 94. North America Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 95. United States Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 96. United States Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 97. United States Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 98. Canada Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 99. Canada Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 100. Canada Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 101. Mexico Separation Systems for Commercial Biotechnology, by Application USD Million (2015-2020)
  • Table 102. Mexico Separation Systems for Commercial Biotechnology, by End-User USD Million (2015-2020)
  • Table 103. Mexico Separation Systems for Commercial Biotechnology, by Method USD Million (2015-2020)
  • Table 104. Separation Systems for Commercial Biotechnology Sales: by Application(K Units)
  • Table 105. Separation Systems for Commercial Biotechnology Sales Vaccines , by Region K Units (2015-2020)
  • Table 106. Separation Systems for Commercial Biotechnology Sales Hormones , by Region K Units (2015-2020)
  • Table 107. Separation Systems for Commercial Biotechnology Sales Proteins , by Region K Units (2015-2020)
  • Table 108. Separation Systems for Commercial Biotechnology Sales Enzymes , by Region K Units (2015-2020)
  • Table 109. Separation Systems for Commercial Biotechnology Sales Others , by Region K Units (2015-2020)
  • Table 110. Separation Systems for Commercial Biotechnology Sales: by End-User(K Units)
  • Table 111. Separation Systems for Commercial Biotechnology Sales Pharmaceutical , by Region K Units (2015-2020)
  • Table 112. Separation Systems for Commercial Biotechnology Sales Food & Cosmetics , by Region K Units (2015-2020)
  • Table 113. Separation Systems for Commercial Biotechnology Sales Agriculture , by Region K Units (2015-2020)
  • Table 114. Separation Systems for Commercial Biotechnology Sales Life Sciences Research , by Region K Units (2015-2020)
  • Table 115. Separation Systems for Commercial Biotechnology Sales Others , by Region K Units (2015-2020)
  • Table 116. Separation Systems for Commercial Biotechnology Sales: by Method(K Units)
  • Table 117. Separation Systems for Commercial Biotechnology Sales Liquid Chromatography , by Region K Units (2015-2020)
  • Table 118. Separation Systems for Commercial Biotechnology Sales Membrane Filtration , by Region K Units (2015-2020)
  • Table 119. Separation Systems for Commercial Biotechnology Sales Electrophoresis , by Region K Units (2015-2020)
  • Table 120. Separation Systems for Commercial Biotechnology Sales Niche Separation , by Region K Units (2015-2020)
  • Table 121. Separation Systems for Commercial Biotechnology Sales Centrifugation , by Region K Units (2015-2020)
  • Table 122. Separation Systems for Commercial Biotechnology Sales Lab-on-a-Chip , by Region K Units (2015-2020)
  • Table 123. Separation Systems for Commercial Biotechnology Sales Others , by Region K Units (2015-2020)
  • Table 124. South America Separation Systems for Commercial Biotechnology Sales, by Country K Units (2015-2020)
  • Table 125. South America Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 126. South America Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 127. South America Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 128. Brazil Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 129. Brazil Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 130. Brazil Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 131. Argentina Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 132. Argentina Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 133. Argentina Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 134. Rest of South America Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 135. Rest of South America Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 136. Rest of South America Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 137. Asia Pacific Separation Systems for Commercial Biotechnology Sales, by Country K Units (2015-2020)
  • Table 138. Asia Pacific Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 139. Asia Pacific Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 140. Asia Pacific Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 141. China Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 142. China Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 143. China Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 144. Japan Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 145. Japan Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 146. Japan Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 147. India Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 148. India Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 149. India Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 150. South Korea Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 151. South Korea Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 152. South Korea Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 153. Taiwan Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 154. Taiwan Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 155. Taiwan Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 156. Australia Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 157. Australia Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 158. Australia Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 159. Rest of Asia-Pacific Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 160. Rest of Asia-Pacific Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 161. Rest of Asia-Pacific Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 162. Europe Separation Systems for Commercial Biotechnology Sales, by Country K Units (2015-2020)
  • Table 163. Europe Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 164. Europe Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 165. Europe Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 166. Germany Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 167. Germany Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 168. Germany Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 169. France Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 170. France Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 171. France Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 172. Italy Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 173. Italy Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 174. Italy Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 175. United Kingdom Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 176. United Kingdom Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 177. United Kingdom Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 178. Netherlands Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 179. Netherlands Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 180. Netherlands Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 181. Rest of Europe Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 182. Rest of Europe Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 183. Rest of Europe Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 184. MEA Separation Systems for Commercial Biotechnology Sales, by Country K Units (2015-2020)
  • Table 185. MEA Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 186. MEA Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 187. MEA Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 188. Middle East Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 189. Middle East Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 190. Middle East Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 191. Africa Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 192. Africa Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 193. Africa Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 194. North America Separation Systems for Commercial Biotechnology Sales, by Country K Units (2015-2020)
  • Table 195. North America Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 196. North America Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 197. North America Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 198. United States Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 199. United States Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 200. United States Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 201. Canada Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 202. Canada Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 203. Canada Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 204. Mexico Separation Systems for Commercial Biotechnology Sales, by Application K Units (2015-2020)
  • Table 205. Mexico Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2015-2020)
  • Table 206. Mexico Separation Systems for Commercial Biotechnology Sales, by Method K Units (2015-2020)
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Company Basic Information, Sales Area and Its Competitors
  • Table 215. Company Basic Information, Sales Area and Its Competitors
  • Table 216. Company Basic Information, Sales Area and Its Competitors
  • Table 217. Separation Systems for Commercial Biotechnology: by Application(USD Million)
  • Table 218. Separation Systems for Commercial Biotechnology Vaccines , by Region USD Million (2021-2026)
  • Table 219. Separation Systems for Commercial Biotechnology Hormones , by Region USD Million (2021-2026)
  • Table 220. Separation Systems for Commercial Biotechnology Proteins , by Region USD Million (2021-2026)
  • Table 221. Separation Systems for Commercial Biotechnology Enzymes , by Region USD Million (2021-2026)
  • Table 222. Separation Systems for Commercial Biotechnology Others , by Region USD Million (2021-2026)
  • Table 223. Separation Systems for Commercial Biotechnology: by End-User(USD Million)
  • Table 224. Separation Systems for Commercial Biotechnology Pharmaceutical , by Region USD Million (2021-2026)
  • Table 225. Separation Systems for Commercial Biotechnology Food & Cosmetics , by Region USD Million (2021-2026)
  • Table 226. Separation Systems for Commercial Biotechnology Agriculture , by Region USD Million (2021-2026)
  • Table 227. Separation Systems for Commercial Biotechnology Life Sciences Research , by Region USD Million (2021-2026)
  • Table 228. Separation Systems for Commercial Biotechnology Others , by Region USD Million (2021-2026)
  • Table 229. Separation Systems for Commercial Biotechnology: by Method(USD Million)
  • Table 230. Separation Systems for Commercial Biotechnology Liquid Chromatography , by Region USD Million (2021-2026)
  • Table 231. Separation Systems for Commercial Biotechnology Membrane Filtration , by Region USD Million (2021-2026)
  • Table 232. Separation Systems for Commercial Biotechnology Electrophoresis , by Region USD Million (2021-2026)
  • Table 233. Separation Systems for Commercial Biotechnology Niche Separation , by Region USD Million (2021-2026)
  • Table 234. Separation Systems for Commercial Biotechnology Centrifugation , by Region USD Million (2021-2026)
  • Table 235. Separation Systems for Commercial Biotechnology Lab-on-a-Chip , by Region USD Million (2021-2026)
  • Table 236. Separation Systems for Commercial Biotechnology Others , by Region USD Million (2021-2026)
  • Table 237. South America Separation Systems for Commercial Biotechnology, by Country USD Million (2021-2026)
  • Table 238. South America Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 239. South America Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 240. South America Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 241. Brazil Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 242. Brazil Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 243. Brazil Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 244. Argentina Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 245. Argentina Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 246. Argentina Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 247. Rest of South America Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 248. Rest of South America Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 249. Rest of South America Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 250. Asia Pacific Separation Systems for Commercial Biotechnology, by Country USD Million (2021-2026)
  • Table 251. Asia Pacific Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 252. Asia Pacific Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 253. Asia Pacific Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 254. China Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 255. China Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 256. China Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 257. Japan Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 258. Japan Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 259. Japan Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 260. India Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 261. India Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 262. India Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 263. South Korea Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 264. South Korea Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 265. South Korea Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 266. Taiwan Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 267. Taiwan Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 268. Taiwan Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 269. Australia Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 270. Australia Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 271. Australia Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 272. Rest of Asia-Pacific Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 273. Rest of Asia-Pacific Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 274. Rest of Asia-Pacific Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 275. Europe Separation Systems for Commercial Biotechnology, by Country USD Million (2021-2026)
  • Table 276. Europe Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 277. Europe Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 278. Europe Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 279. Germany Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 280. Germany Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 281. Germany Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 282. France Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 283. France Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 284. France Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 285. Italy Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 286. Italy Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 287. Italy Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 288. United Kingdom Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 289. United Kingdom Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 290. United Kingdom Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 291. Netherlands Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 292. Netherlands Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 293. Netherlands Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 294. Rest of Europe Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 295. Rest of Europe Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 296. Rest of Europe Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 297. MEA Separation Systems for Commercial Biotechnology, by Country USD Million (2021-2026)
  • Table 298. MEA Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 299. MEA Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 300. MEA Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 301. Middle East Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 302. Middle East Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 303. Middle East Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 304. Africa Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 305. Africa Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 306. Africa Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 307. North America Separation Systems for Commercial Biotechnology, by Country USD Million (2021-2026)
  • Table 308. North America Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 309. North America Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 310. North America Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 311. United States Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 312. United States Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 313. United States Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 314. Canada Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 315. Canada Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 316. Canada Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 317. Mexico Separation Systems for Commercial Biotechnology, by Application USD Million (2021-2026)
  • Table 318. Mexico Separation Systems for Commercial Biotechnology, by End-User USD Million (2021-2026)
  • Table 319. Mexico Separation Systems for Commercial Biotechnology, by Method USD Million (2021-2026)
  • Table 320. Separation Systems for Commercial Biotechnology Sales: by Application(K Units)
  • Table 321. Separation Systems for Commercial Biotechnology Sales Vaccines , by Region K Units (2021-2026)
  • Table 322. Separation Systems for Commercial Biotechnology Sales Hormones , by Region K Units (2021-2026)
  • Table 323. Separation Systems for Commercial Biotechnology Sales Proteins , by Region K Units (2021-2026)
  • Table 324. Separation Systems for Commercial Biotechnology Sales Enzymes , by Region K Units (2021-2026)
  • Table 325. Separation Systems for Commercial Biotechnology Sales Others , by Region K Units (2021-2026)
  • Table 326. Separation Systems for Commercial Biotechnology Sales: by End-User(K Units)
  • Table 327. Separation Systems for Commercial Biotechnology Sales Pharmaceutical , by Region K Units (2021-2026)
  • Table 328. Separation Systems for Commercial Biotechnology Sales Food & Cosmetics , by Region K Units (2021-2026)
  • Table 329. Separation Systems for Commercial Biotechnology Sales Agriculture , by Region K Units (2021-2026)
  • Table 330. Separation Systems for Commercial Biotechnology Sales Life Sciences Research , by Region K Units (2021-2026)
  • Table 331. Separation Systems for Commercial Biotechnology Sales Others , by Region K Units (2021-2026)
  • Table 332. Separation Systems for Commercial Biotechnology Sales: by Method(K Units)
  • Table 333. Separation Systems for Commercial Biotechnology Sales Liquid Chromatography , by Region K Units (2021-2026)
  • Table 334. Separation Systems for Commercial Biotechnology Sales Membrane Filtration , by Region K Units (2021-2026)
  • Table 335. Separation Systems for Commercial Biotechnology Sales Electrophoresis , by Region K Units (2021-2026)
  • Table 336. Separation Systems for Commercial Biotechnology Sales Niche Separation , by Region K Units (2021-2026)
  • Table 337. Separation Systems for Commercial Biotechnology Sales Centrifugation , by Region K Units (2021-2026)
  • Table 338. Separation Systems for Commercial Biotechnology Sales Lab-on-a-Chip , by Region K Units (2021-2026)
  • Table 339. Separation Systems for Commercial Biotechnology Sales Others , by Region K Units (2021-2026)
  • Table 340. South America Separation Systems for Commercial Biotechnology Sales, by Country K Units (2021-2026)
  • Table 341. South America Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 342. South America Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 343. South America Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 344. Brazil Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 345. Brazil Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 346. Brazil Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 347. Argentina Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 348. Argentina Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 349. Argentina Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 350. Rest of South America Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 351. Rest of South America Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 352. Rest of South America Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 353. Asia Pacific Separation Systems for Commercial Biotechnology Sales, by Country K Units (2021-2026)
  • Table 354. Asia Pacific Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 355. Asia Pacific Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 356. Asia Pacific Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 357. China Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 358. China Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 359. China Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 360. Japan Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 361. Japan Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 362. Japan Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 363. India Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 364. India Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 365. India Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 366. South Korea Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 367. South Korea Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 368. South Korea Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 369. Taiwan Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 370. Taiwan Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 371. Taiwan Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 372. Australia Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 373. Australia Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 374. Australia Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 375. Rest of Asia-Pacific Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 376. Rest of Asia-Pacific Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 377. Rest of Asia-Pacific Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 378. Europe Separation Systems for Commercial Biotechnology Sales, by Country K Units (2021-2026)
  • Table 379. Europe Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 380. Europe Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 381. Europe Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 382. Germany Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 383. Germany Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 384. Germany Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 385. France Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 386. France Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 387. France Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 388. Italy Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 389. Italy Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 390. Italy Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 391. United Kingdom Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 392. United Kingdom Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 393. United Kingdom Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 394. Netherlands Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 395. Netherlands Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 396. Netherlands Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 397. Rest of Europe Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 398. Rest of Europe Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 399. Rest of Europe Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 400. MEA Separation Systems for Commercial Biotechnology Sales, by Country K Units (2021-2026)
  • Table 401. MEA Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 402. MEA Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 403. MEA Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 404. Middle East Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 405. Middle East Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 406. Middle East Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 407. Africa Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 408. Africa Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 409. Africa Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 410. North America Separation Systems for Commercial Biotechnology Sales, by Country K Units (2021-2026)
  • Table 411. North America Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 412. North America Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 413. North America Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 414. United States Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 415. United States Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 416. United States Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 417. Canada Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 418. Canada Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 419. Canada Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 420. Mexico Separation Systems for Commercial Biotechnology Sales, by Application K Units (2021-2026)
  • Table 421. Mexico Separation Systems for Commercial Biotechnology Sales, by End-User K Units (2021-2026)
  • Table 422. Mexico Separation Systems for Commercial Biotechnology Sales, by Method K Units (2021-2026)
  • Table 423. Research Programs/Design for This Report
  • Table 424. Key Data Information from Secondary Sources
  • Table 425. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Separation Systems for Commercial Biotechnology: by Application USD Million (2015-2020)
  • Figure 5. Global Separation Systems for Commercial Biotechnology: by End-User USD Million (2015-2020)
  • Figure 6. Global Separation Systems for Commercial Biotechnology: by Method USD Million (2015-2020)
  • Figure 7. South America Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 8. Asia Pacific Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 9. Europe Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 10. MEA Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 11. North America Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 12. Global Separation Systems for Commercial Biotechnology: by Application K Units (2015-2020)
  • Figure 13. Global Separation Systems for Commercial Biotechnology: by End-User K Units (2015-2020)
  • Figure 14. Global Separation Systems for Commercial Biotechnology: by Method K Units (2015-2020)
  • Figure 15. South America Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 16. Asia Pacific Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 17. Europe Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 18. MEA Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 19. North America Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 20. Global Separation Systems for Commercial Biotechnology share by Players 2020 (%)
  • Figure 21. Global Separation Systems for Commercial Biotechnology share by Players (Top 3) 2020(%)
  • Figure 22. Global Separation Systems for Commercial Biotechnology share by Players (Top 5) 2020(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 25. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 26. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 28. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 29. Agilent Technologies (United States) Revenue: by Geography 2020
  • Figure 30. Waters Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Waters Corporation (United States) Revenue: by Geography 2020
  • Figure 32. Shimadzu Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 33. Shimadzu Corporation (Japan) Revenue: by Geography 2020
  • Figure 34. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 35. Bio-Rad Laboratories (United States) Revenue: by Geography 2020
  • Figure 36. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. Merck & Co., Inc. (United States) Revenue: by Geography 2020
  • Figure 38. QIAGEN (Germany) Revenue, Net Income and Gross profit
  • Figure 39. QIAGEN (Germany) Revenue: by Geography 2020
  • Figure 40. Sartorius (Germany) Revenue, Net Income and Gross profit
  • Figure 41. Sartorius (Germany) Revenue: by Geography 2020
  • Figure 42. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 43. PerkinElmer, Inc. (United States) Revenue: by Geography 2020
  • Figure 44. Global Separation Systems for Commercial Biotechnology: by Application USD Million (2021-2026)
  • Figure 45. Global Separation Systems for Commercial Biotechnology: by End-User USD Million (2021-2026)
  • Figure 46. Global Separation Systems for Commercial Biotechnology: by Method USD Million (2021-2026)
  • Figure 47. South America Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 48. Asia Pacific Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 49. Europe Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 50. MEA Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 51. North America Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 52. Global Separation Systems for Commercial Biotechnology: by Application K Units (2021-2026)
  • Figure 53. Global Separation Systems for Commercial Biotechnology: by End-User K Units (2021-2026)
  • Figure 54. Global Separation Systems for Commercial Biotechnology: by Method K Units (2021-2026)
  • Figure 55. South America Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 56. Asia Pacific Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 57. Europe Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 58. MEA Separation Systems for Commercial Biotechnology Share (%), by Country
  • Figure 59. North America Separation Systems for Commercial Biotechnology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (United States)
  • Danaher Corporation (United States)
  • Agilent Technologies (United States)
  • Waters Corporation (United States)
  • Shimadzu Corporation (Japan)
  • Bio-Rad Laboratories (United States)
  • Merck & Co., Inc. (United States)
  • QIAGEN (Germany)
  • Sartorius (Germany)
  • PerkinElmer, Inc. (United States)
Additional players considered in the study are as follows:
Hitachi Koki Co. (Japan) , Miltenyi Biotec (Germany) , Varian (United States) , Affymetrix (United States) , Alfa Wassermann (United States)
Select User Access Type

Key Highlights of Report


May 2021 238 Pages 64 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Separation Systems for Commercial Biotechnology Quantitative research analysis
Global Separation Systems for Commercial Biotechnology Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Separation Systems for Commercial Biotechnology Report?

Have a Query? Click Here

Other Related Reports

Lab Dishes Comprehensive Study by Type (Reusable, Disposable), Application (University Laboratory, Research Laboratory, Other), Dish Type (Petri Dishes, Evaporating Dishes, Crystallizing Dishes, Othe...
$ 3350
Animal Vaccine Comprehensive Study by Type (Live attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Recombinant vaccines, Other vaccines.), Application (Porcine, Poultry, Livestock, Companio...
$ 3350
Animal Model Comprehensive Study by Type (Rats, Mice, Rabbits, Dogs, Pigs, Cats, Others), Application (Physiology, Toxicology, Cancer Research, Neurological Research, Biomedical Research, Genetic Res...
$ 3750
Stem Cell Banking Comprehensive Study by Type (Umbilical Cord Blood Stem Cell, Embryonic Stem Cell, Adult Stem Cell, Others), Application (Personalized Banking Applications, Research Applications {Di...
$ 3750
Hemostasis and Tissue Sealing Agents Comprehensive Study by Type (Topical Hemostats (Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Fibrin Sealants, and Topical Thrombin Products), Adhes...
$ 3750
Direct-Fed Microbials Comprehensive Study by Type (Lactic Acid Bacteria,, Bacillus subtilis, Yeast, Others), Application (Poultry, Swine, Ruminants, Aquatic Animals, Others), Form (Dry, Liquid), Dist...
$ 3450